###begin article-title 0
Matrix Metalloproteinase 13 Is Induced in Fibroblasts in Polyomavirus Middle T Antigen-Driven Mammary Carcinoma without Influencing Tumor Progression
###end article-title 0
###begin p 1
Conceived and designed the experiments: BSN ME ZW LRL. Performed the experiments: BSN ME CJP TXP LRL. Analyzed the data: BSN ME FR HAA CJP TXP IJC LRL. Contributed reagents/materials/analysis tools: DRE ZW. Wrote the paper: BSN ME. Critically revised the manuscript: DRE ZW LL.
###end p 1
###begin p 2
Current address: Exiqon A/S, Diagnostic Product Development, Vedbaek, Denmark
###end p 2
###begin p 3
Current address: Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
###end p 3
###begin p 4
###xml 350 355 350 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 478 483 478 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 715 720 715 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 1087 1090 1087 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1072 1090 1072 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 1118 1121 1118 1121 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1103 1121 1103 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 1243 1248 1243 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 325 330 <span type="species:ncbi:10090">mouse</span>
###xml 338 342 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 464 469 <span type="species:ncbi:9606">human</span>
###xml 695 699 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 705 709 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
###xml 1072 1076 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1103 1107 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1302 1306 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1381 1386 <span type="species:ncbi:9606">human</span>
###xml 1585 1589 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Matrix metalloproteinase (MMP) 13 (collagenase 3) is an extracellular matrix remodeling enzyme that is induced in myofibroblasts during the earliest invasive stages of human breast carcinoma, suggesting that it is involved in tumor progression. During progression of mammary carcinomas in the polyoma virus middle T oncogene mouse model (MMTV-PyMT), Mmp13 mRNA was strongly upregulated concurrently with the transition to invasive and metastatic carcinomas. As in human tumors, Mmp13 mRNA was found in myofibroblasts of invasive grade II and III carcinomas, but not in benign grade I and II mammary intraepithelial neoplasias. To determine if MMP13 plays a role in tumor progression, we crossed MMTV-PyMT mice with Mmp13 deficient mice. The absence of MMP13 did not influence tumor growth, vascularization, progression to more advanced tumor stages, or metastasis to the lungs, and the absence of MMP13 was not compensated for by expression of other MMPs or tissue inhibitor of metalloproteinases. However, an increased fraction of thin collagen fibrils was identified in MMTV-PyMT;Mmp13-/- compared to MMTV-PyMT;Mmp13+/+ tumors, showing that collagen metabolism was altered in the absence of MMP13. We conclude that the expression pattern of Mmp13 mRNA in myofibroblasts of invasive carcinomas in the MMTV-PyMT breast cancer model recapitulates the expression pattern observed in human breast cancer. Our results suggest that MMP13 is a marker of carcinoma-associated myofibroblasts of invasive carcinoma, even though it does not make a major contribution to tumor progression in the MMTV-PyMT breast cancer model.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 282 285 282 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Ferguson1">[1]</xref>
###xml 287 290 287 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lochter1">[2]</xref>
###xml 358 361 358 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Egeblad1">[3]</xref>
###xml 466 473 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 473 476 473 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Egeblad1">[3]</xref>
###xml 477 480 477 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Szabova1">[7]</xref>
The ability of cancer cells to invade or metastasize to distant organs is linked to their ability to traverse the extracellular matrix. The extracellular matrix (ECM) is a heterogeneous protein matrix that consists of a variety of collagens, laminins, fibronectin and proteoglycans [1], [2]. Matrix metalloproteinases (MMP) cleave and remodel ECM components [3], and increased activity of some of the MMPs, including MMP2, 9, and 14 can promote cancer cell invasion in vivo[3]-[7].
###end p 6
###begin p 7
###xml 78 81 78 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Freije1">[8]</xref>
###xml 226 229 226 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Knauper1">[9]</xref>
###xml 244 248 244 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Cowell1">[10]</xref>
###xml 362 366 362 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Knauper2">[11]</xref>
###xml 368 373 368 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen1">[12]</xref>
###xml 652 657 652 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 686 690 686 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen1">[12]</xref>
###xml 692 696 692 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen2">[13]</xref>
###xml 723 728 723 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 770 774 770 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 776 781 776 781 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp11</italic>
###xml 786 791 786 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp14</italic>
###xml 813 818 813 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 920 924 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen1">[12]</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
MMP13 (collagenase-3) was originally identified in human breast cancer tissue [8]. It is secreted from cells as an inactive zymogen that can be activated by the MMP2/MMP14/tissue inhibitor of metalloproteinase (TIMP2) complex [9] or by plasmin [10]. MMP13 acts in the extracellular environment as a potent collagenase capable of degrading a variety of collagens [11]. Mmp13 mRNA is expressed in a subpopulation of myofibroblasts in invasive ductal breast carcinomas [12], but rarely in normal breast, benign breast lesions and ductal carcinoma in situ (DCIS). Interestingly, the presence of microinvasion in DCIS is associated with focal expression of Mmp13 mRNA in stromal fibroblasts [12], [13]. Direct comparison of the Mmp13 mRNA expression pattern with that of the Mmp2, Mmp11 and Mmp14 mRNAs indicates that Mmp13 is unique in this respect since these other MMPs are also present in DCIS in the absence of invasion [12]. These observations raise the question as to whether MMP13 is a rate-limiting proteinase that mediates the initial steps in breast cancer invasion.
###end p 7
###begin p 8
###xml 150 153 150 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Almholt1">[6]</xref>
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Guy1">[14]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lin1">[15]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Guy1">[14]</xref>
###xml 731 735 731 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lin1">[15]</xref>
###xml 737 741 737 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-KourosMehr1">[16]</xref>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lin1">[15]</xref>
###xml 1053 1057 1053 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Guy1">[14]</xref>
###xml 1059 1063 1059 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lin1">[15]</xref>
###xml 1169 1173 1169 1173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Guy1">[14]</xref>
###xml 1175 1179 1175 1179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lin1">[15]</xref>
###xml 1181 1185 1181 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Maglione1">[17]</xref>
###xml 1186 1190 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Herschkowitz1">[19]</xref>
###xml 1227 1231 1227 1231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 1233 1242 1233 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3, 11, 13</italic>
###xml 1247 1249 1247 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</italic>
###xml 1398 1402 1398 1402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Pedersen1">[18]</xref>
###xml 1426 1431 1426 1431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 1494 1498 1494 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Pedersen2">[20]</xref>
###xml 1590 1594 1590 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen1">[12]</xref>
###xml 122 128 <span type="species:ncbi:10090">murine</span>
###xml 242 267 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 273 277 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 470 475 <span type="species:ncbi:9606">human</span>
###xml 530 534 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 540 545 <span type="species:ncbi:10090">mouse</span>
###xml 924 928 <span type="species:ncbi:10090">mice</span>
###xml 1136 1141 <span type="species:ncbi:9606">human</span>
###xml 1323 1327 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1370 1375 <span type="species:ncbi:9606">human</span>
###xml 1569 1574 <span type="species:ncbi:9606">human</span>
###xml 1609 1613 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1619 1624 <span type="species:ncbi:10090">mouse</span>
The role of MMPs and other ECM-degrading proteinases during breast cancer progression has been studied using a variety of murine mammary tumor models [6]. In one model, tumors are induced by expressing the polyoma middle T oncogene under the mouse mammary tumor virus LTR (MMTV-PyMT) [14] leading to early onset hyperplasia in the mammary glands [15]. The PyMT-oncogene induced mammary tumors go through typical pre-invasive, invasive and metastatic phases similarly to human breast cancer [14]. The onset of tumorigenesis in the MMTV-PyMT mouse model is observed at 2-3 weeks after birth, and the non-invasive early stage tumors, mammary intraepithelial neoplasia (MIN), progress into invasive carcinomas at 7-9 weeks after birth [15], [16]. Transition to invasive carcinoma takes place in the central core of the tumors, where epithelial atypia and nuclear pleomorphism first appear [15]. Tumors isolated from 13-week-old mice, late stage tumors, show evidence of dedifferentiation and squamous metaplasia and have spread to the lungs and lymph nodes [14], [15]. The tumors share both morphological and molecular characteristics with human invasive ductal carcinomas [14], [15], [17]-[19]. Furthermore, we have reported that Mmp2, 3, 11, 13 and 14 mRNAs are expressed in the stromal compartment in a series of late stage MMTV-PyMT tumors, similar to the expression in human ductal breast cancers [18]. In late stage tumors, Mmp13 mRNA shows high, focal expression in stromal cell populations [20]. Since this expression pattern is similar to what we have observed in human breast cancers [12], we chose the MMTV-PyMT mouse breast tumor model to test the functional role of MMP13 in breast cancer progression and metastasis.
###end p 8
###begin title 9
Materials and Methods
###end title 9
###begin title 10
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 10
###begin p 11
###xml 19 22 19 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 14 22 14 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 59 63 59 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Guy1">[14]</xref>
###xml 65 69 65 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Stickens1">[21]</xref>
###xml 202 205 202 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 187 205 187 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/&#8722;</sup></italic>
###xml 249 252 249 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 244 252 244 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13<sup>+/&#8722;</sup></italic>
###xml 305 308 305 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 290 308 290 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 328 331 328 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 313 331 313 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 0 4 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 187 191 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 290 294 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 313 317 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
MMTV-PyMT and Mmp13-/- mice have previously been described [14], [21]. Both strains were backcrossed more than 8 generations to FVB/n. The two strains were intercrossed and the resulting MMTV-PyMT;Mmp13+/- male offspring were mated with female Mmp13+/- mice to establish sibling cohorts of MMTV-PyMT;Mmp13+/+ and MMTV-PyMT;Mmp13-/- females. All animal experiments were conducted according to institutional guidelines and approved by the Danish Animal Experiments Inspectorate. A concurrent health report compliant with the guidelines of the Federation of European Laboratory Animal Science Associations revealed no infections.
###end p 11
###begin title 12
Genotyping
###end title 12
###begin p 13
###xml 68 72 68 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Laird1">[22]</xref>
###xml 104 113 104 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT</italic>
###xml 134 145 134 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasminogen</italic>
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Bugge1">[23]</xref>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 194 227 194 227 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGT GGT ATG AAC AAG TTT TCT GAG C</named-content>
###xml 240 273 240 273 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CAG ACC CTA CAG TGC CAG ATT TTA G</named-content>
###xml 286 319 286 319 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGA TGA CGT TCA AGG AAT TCA GTT T</named-content>
###xml 341 350 341 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT</italic>
###xml 371 382 371 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">plasminogen</italic>
###xml 396 401 396 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 104 108 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 341 345 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Genotyping was performed on chromosomal DNA purified from tail tips [22] in a single PCR reaction using MMTV-PyMT primers, control wt plasminogen primers [23] and Mmp13 primers (MMP13_in5 anti: GGT GGT ATG AAC AAG TTT TCT GAG C, MMP13_in2: CAG ACC CTA CAG TGC CAG ATT TTA G, MMP13_ex5: TGA TGA CGT TCA AGG AAT TCA GTT T). Bands representing MMTV-PyMT transgene (159 bp), plasminogen (268 bp), wt Mmp13 (572 bp) and Mmp13 knock-out allele (672 bp) were identified by agarose gel electrophoresis.
###end p 13
###begin title 14
Quantitative real time PCR
###end title 14
###begin p 15
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 611 614 611 614 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 596 614 596 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 642 645 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 627 645 627 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 938 942 932 936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nuttall1">[24]</xref>
###xml 990 994 984 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Price1">[25]</xref>
###xml 1075 1079 1069 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Wells1">[26]</xref>
###xml 1092 1097 1086 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 1212 1239 1206 1233 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CTT TTC CTC CTG GAC CAA ACT</named-content>
###xml 1248 1274 1242 1268 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCA TGG GCA GCA ACA ATA AA</named-content>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 344 348 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 410 414 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 420 424 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 596 600 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 627 631 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 646 650 <span type="species:ncbi:10090">mice</span>
Mice were anesthetized by intraperitoneal administration of a 1:1 mixture of Dormicum (Roche A/S, Basel, Switzerland) and Hypnorm (Janssen-Cilag Ltd, High Wycombe, UK) and sacrificed by intracardial perfusion with 10 ml ice-cold phosphate-buffered saline (PBS). For analysis of Mmp13 mRNA expression during normal mammary gland development and MMTV-PyMT tumorigenesis, the #4 mammary glands were isolated from MMTV-PyMT mice and wild type FVB/n mice at 3, 5, 7, 9, 11 and 13 weeks (n = 5 for each age and genotype). For analyses of the expression of other MMPs and TIMPs, tumors from 11-week old MMTV-PyMT;Mmp13+/+ (n = 6) and MMTV-PyMT;Mmp13-/- mice were used (n = 6). Total mRNA was isolated from 100 mg tissue using the Qiagen RNeasy midi Kit (Qiagen, West Sussex, UK). The purified RNA samples were treated with DNase I for 15 minutes at 37degreesC to remove residual DNA. Reverse transcription was performed essentially as described [24] followed by TaqMan qPCR performed as described [25] using an ABI7900 (Applied Biosystems, Foster City, CA) and primers specified in [26] except that Mmp13 primers were chosen from the universal probe library (number 105, Roche Applied Science, Burgess Hill, UK), left: CTT TTC CTC CTG GAC CAA ACT, right: TCA TGG GCA GCA ACA ATA AA. Gene expression levels relative to 18S were calculated.
###end p 15
###begin title 16
In situ hybridization
###end title 16
###begin p 17
###xml 260 267 254 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In situ</italic>
###xml 327 330 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 312 330 306 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 350 352 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 407 411 401 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lund1">[27]</xref>
###xml 416 421 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 477 480 471 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 462 480 456 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 12 16 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
###xml 462 466 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 481 485 <span type="species:ncbi:10090">mice</span>
13-week-old mice were anesthetized as above and perfused intracardially with 10 mL PBS followed by 10 mL of 4% paraformaldehyde (PFA). Mammary tumors were dissected from glands #1-3 and #4, fixed in 4% formalin for 5-7 days at 4degreesC and paraffin embedded. In situ hybridization was performed on samples from MMTV-PyMT;Mmp13+/+ mice (n = 10) with 35S labeled RNA probes for MMP13 as described previously [27]. No Mmp13 mRNA signal was detected in tumors from MMTV-PyMT;Mmp13-/- mice (n = 4).
###end p 17
###begin title 18
Immunohistochemistry
###end title 18
###begin p 19
###xml 799 806 785 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 890 893 876 879 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 875 893 861 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 931 935 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen1">[12]</xref>
###xml 1113 1115 1099 1101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 1125 1130 1111 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 1185 1192 1171 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 1231 1235 1217 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lund1">[27]</xref>
###xml 63 68 <span type="species:ncbi:10090">mouse</span>
###xml 110 113 <span type="species:ncbi:10116">rat</span>
###xml 401 406 <span type="species:ncbi:10090">mouse</span>
###xml 535 538 <span type="species:ncbi:10116">rat</span>
###xml 575 581 <span type="species:ncbi:9986">rabbit</span>
###xml 587 590 <span type="species:ncbi:10116">rat</span>
###xml 623 629 <span type="species:ncbi:9986">Rabbit</span>
###xml 838 843 <span type="species:ncbi:10090">mouse</span>
###xml 875 879 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 894 898 <span type="species:ncbi:10090">mice</span>
For immunohistochemical staining of alpha-smooth muscle-actin (mouse mAb, Dako, Glostrup, Denmark) and CD204 (rat mAb clone 2F8, Serotec, Oxford, UK), sections were heat-treated at 98degreesC in TEG buffer (10 mmol/L Tris, 0.5 mmol/L EGTA, pH 9.0) for 5 minutes in a T/T Micromed microwave processor (Milestone, Sorisol, Italy). The alpha-smooth muscle-actin antibody was mixed with biotinylated anti-mouse Fab fragments using the Animal Research Kit (Dako) and used for staining following the recommendations of the manufacturer. The rat mAb against CD204 was detected with rabbit anti-rat antibodies followed by Envision-Rabbit reagent (Dako). All antibody incubation steps were performed in an OptiMax automated immunostainer (BioGenex, San Ramon, CA). Immunohistochemical staining combined with in situ hybridization was performed on mouse glands #1-3 tumor samples from MMTV-PyMT;Mmp13+/+ mice (n = 6) as described previously [12]. The sections were developed with DAB chromogene, fixed for 40 minutes in 4% PFA, and washed three times with sterile water. After dehydration, the sections were incubated with 35S-labeled Mmp13 antisense probes and further treated according to the in situ hybridization as described previously [27].
###end p 19
###begin title 20
Morphometric analysis of mammary gland whole mounts
###end title 20
###begin p 21
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 59 77 59 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 134 137 134 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 119 137 119 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 217 221 217 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Wiseman1">[28]</xref>
###xml 59 63 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 119 123 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
The #4 mammary glands were isolated from 4- and 6-week-old MMTV-PyMT;Mmp13+/+ mice (n = 4 and n = 4, respectively) and MMTV-PyMT;Mmp13-/- mice (n = 3 and n = 7, respectively) and prepared for whole mount as described [28]. The whole mounts were photographed using a DFC320 CCD camera (Leica Microsystems, Wetzlar, Germany) and the ductal epithelial invasion determined by measuring the distance from the branch point closest to the nipple to the three most far-reaching ducts and the edge of the fat pad. The penetration is presented as the mean of the three measures of ductal penetration related to the length to the edge of the fat pad. All measurements were done using the Leica IM500 software.
###end p 21
###begin title 22
Tumor growth and lung metastasis
###end title 22
###begin p 23
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 16 34 16 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 53 71 53 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 321 322 321 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</italic>
###xml 326 328 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#960;</italic>
###xml 332 333 331 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W</italic>
###xml 333 334 332 333 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 335 336 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 344 345 343 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 359 360 358 359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W</italic>
###xml 398 401 397 400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 383 401 382 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 435 438 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 420 438 419 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 706 710 705 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen3">[29]</xref>
###xml 16 20 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 35 39 <span type="species:ncbi:10090">mice</span>
###xml 53 57 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 72 76 <span type="species:ncbi:10090">mice</span>
###xml 383 387 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 420 424 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 498 502 <span type="species:ncbi:10090">mice</span>
Tumor growth in MMTV-PyMT;Mmp13+/+ mice (n = 38) and MMTV-PyMT;Mmp13-/- mice (n = 25) was followed by weekly palpations of all 10 mammary glands. The length and width of all palpable tumors were measured by caliper. The tumor volume (assuming that tumors took the shape of an ellipsoid) was calculated using the formula: V = (pi/6)xW2xL, where L = length and W = width. At 13 weeks, MMTV-PyMT;Mmp13+/+ mice (n = 35) and MMTV-PyMT;Mmp13-/- mice (n = 25) were anesthetized and perfusion fixed (three mice had been terminated before due to extensive tumor burden). The lungs were removed for determination of the metastasis burden by stereological analysis using Cavalieri's principle as described previously [29].
###end p 23
###begin title 24
Tumor grading
###end title 24
###begin p 25
###xml 142 145 142 145 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 127 145 127 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 179 182 179 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 164 182 164 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 412 416 412 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lin1">[15]</xref>
###xml 23 27 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 127 131 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 164 168 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
Nuclear grading of the MMTV-PyMT tumors was performed on haematoxylin and eosin (H&E) stained sections from the #1-3 tumors of MMTV-PyMT;Mmp13+/+ mice (n = 34) and MMTV-PyMT;Mmp13-/- mice (n = 24). We defined grade I tumors as tumors with adenoma and atypia in Mammary Intraepithelial Neoplasia (MIN)-like foci and containing up to 5% of MIN with grade II nuclear pleiomorphy. Grade II tumors ("Early carcinoma" [15]) were tumors with widespread invasive carcinoma with grade II nuclear pleiomorphy and contained areas with MIN Grade I/II. Grade III tumors ("Late carcinoma") were tumors with focal or widespread invasive carcinoma with grade III nuclear pleiomorphy that also contained areas with Grade I and II carcinoma. Most tumors with grade III carcinoma showed areas of squamous metaplasia.
###end p 25
###begin title 26
Quantification of angiogenesis
###end title 26
###begin p 27
###xml 74 97 70 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lycopersicon esculentum</italic>
###xml 137 141 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.v.</italic>
###xml 1444 1447 1432 1435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1429 1447 1417 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 1483 1486 1471 1474 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1468 1486 1456 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 74 97 <span type="species:ncbi:4081">Lycopersicon esculentum</span>
###xml 99 105 <span type="species:ncbi:4081">tomato</span>
###xml 177 181 <span type="species:ncbi:10090">mice</span>
###xml 1429 1433 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1468 1472 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Mice were anesthetized as above and 100 microL of 1 mg/mL FITC-conjugated Lycopersicon esculentum (tomato) lectin (Vector labs) injected i.v. in the tail vein. After 5 min, the mice were cardiac perfused with 4% PFA in PBS at 120-140 mm Hg until the flow-through fluid was clear. Tumors were dissected and post-fixed in 4% PFA overnight, incubated in increasing sucrose concentrations (12%, 15%, 18% in PBS), embedded in Tissue-Tek O.C.T. compound and thick sections (30-40 microm) cut. The tissue sections were stained with 1:500 solution of Propidium Iodide in PBS (Molecular probes, P-3566) for 1 hour and the slides were mounted with Gel/Mount (Biomeda, #M01). Confocal image stacks with 1-microm spacing were collected from the most vascularized area in the middle of the tumors using a 20x lens with a Solamere micro-lensed spinning disk confocal microscope (Solamere Technologies, Salt Lake City UT) equipped with an intensified charge-coupled device (ICCD) camera (XRMega-10EX S-30, Stanford Photonics, Palo Alto, CA). The acquired images were analyzed with Bitplane Imaris version 5.5 for Windows software using 'filament tracer' with an approximate filament diameter set at 1.5. Minor manual corrections of the computerized filaments were uniformly done. Vessel (segment) average diameter, length and volume, were exported to a Microsoft Excel file and analyzed using GraphPad 4 statistical software. Eight tumors from MMTV-PyMT;Mmp13+/+ and nine tumor from MMTV-PyMT;Mmp13-/- were analyzed. All image acquisition and analysis was done blindly.
###end p 27
###begin title 28
Cell proliferation analysis
###end title 28
###begin p 29
###xml 15 18 15 18 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 52 55 52 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 37 55 37 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 84 88 84 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.p.</italic>
###xml 597 601 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Green1">[30]</xref>
###xml 634 635 626 627 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1010 1014 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Green1">[30]</xref>
###xml 0 4 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 37 41 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 337 340 <span type="species:ncbi:10116">rat</span>
MMTV-PyMT;Mmp13+/+ mice (n = 19) and MMTV-PyMT;Mmp13-/- mice (n = 19) were injected i.p. with 2 mg bromodeoxyuridine (BrdU, Sigma-Aldrich) 2 hours before euthanasia. The mice were anesthetized, perfusion fixed, the tumors isolated and fixed in 4% PFA and finally paraffin embedded as described above. For immunohistochemistry, we used a rat mAb against BrdU at 2 microg/mL (clone BU1/75-ICR1, Abcam, Cambridge, UK). The BrdU labeled cells were counted as a percentage of the total number of epithelial tumor cells using CastGRID (Visiopharm, Horsholm, Denmark) essentially as previously described [30]. In brief, frames of 9391 microm2 were systematically but randomly placed over the BrdU stained sections with a final magnification of 658 on the monitor. All BrdU positive neoplastic cells within the frames were counted to give total numbers varying from 250-400. The total number of neoplastic cells within the frames was estimated based on the usage of systematic and randomly positioned reference points [30].
###end p 29
###begin title 30
Collagen evaluation
###end title 30
###begin p 31
###xml 105 108 101 104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 90 108 86 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 142 145 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 127 145 123 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 232 236 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Junqueira1">[31]</xref>
###xml 612 616 608 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Dayan1">[32]</xref>
###xml 90 94 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 127 131 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
Serial sections (3-microm thick) from mammary tumor glands #1-3 obtained from 13-week-old MMTV-PyMT;Mmp13+/+ mice (n = 26) and MMTV-PyMT;Mmp13-/- mice (n = 21) were stained with haematoxylin and eosin (H&E) or picrosirius red (PSR) [31]. Areas with invasive tumor were identified in H&E stained sections. The same areas were then analyzed in the PSR stained sections by obtaining 2.3x1.8 mm images with a charge-coupled device (CCD) camera (Leica) under linearly polarized light using a Leica DMRBE microscope. In linearly polarized light, thick collagen bundles appear orange-red and thin collagen fibers green [32]. Images were analyzed with MetaMorph software for collagen content. Total collagen was identified with Hue-Saturation-Intensity (HSI) intervals 0-256, 1-256 and 70-256, respectively. For thin fibrillar collagen, HSI settings of 26-83, 70-135, and 57-155 were applied to all the images. All image acquisition and analysis was done blindly. The area covered by total collagen, thin fibrillar collagen, and the fraction of thin fibrillar collagen was calculated and used for statistical analysis (t-test).
###end p 31
###begin title 32
Statistics
###end title 32
###begin p 33
For statistical analyses of the tumor burdens obtained by caliber measurements, the total tumor volumes were logarithmically transformed and analyzed using a general linear model with repeated measures. Only measurements obtained from week 7 to 13 were included in this analysis. Estimates were obtained using generalized estimating equations (SAS v9.1). Statistical interaction between genotype and time were evaluated for the entire observation period considering repeated measures (SAS). For statistical analyses of the metastasis burdens, the values were logarithmically transformed and analyzed using a general linear model.
###end p 33
###begin title 34
Results
###end title 34
###begin title 35
###xml 55 59 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Mmp13 is expressed by myofibroblasts in invasive stage MMTV-PyMT tumors
###end title 35
###begin p 36
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen1">[12]</xref>
###xml 320 325 320 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 421 426 421 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 576 582 576 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g001">Fig. 1</xref>
###xml 585 590 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 666 671 666 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 762 766 762 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lin1">[15]</xref>
###xml 64 69 <span type="species:ncbi:9606">human</span>
###xml 297 301 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 307 312 <span type="species:ncbi:10090">mouse</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 456 460 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 534 538 <span type="species:ncbi:10090">mice</span>
Mmp13 mRNA is expressed by a subpopulation of myofibroblasts in human invasive ductal breast carcinomas, but is rarely expressed in normal breast, benign breast lesions and ductal carcinoma in situ (DCIS) [12]. To determine if the expression level of MMP13 changes during tumor progression in the MMTV-PyMT mouse model, Mmp13 mRNA levels were assessed in tumor tissue from mice at 3-13 weeks of age by qPCR. The level of Mmp13 mRNA was highly increased in MMTV-PyMT tumors after 7-weeks of age, with the highest levels found in older mice, corresponding to late stage tumors (Fig. 1). Mmp13 mRNA levels were low in normal mammary glands at all ages. The increase in Mmp13 mRNA thus took place during the time of transition to invasive stages in this tumor model [15].
###end p 36
###begin title 37
###xml 57 61 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Expression of Mmp13 mRNA is induced at 7 weeks of age in MMTV-PyMT tumors.
###end title 37
###begin p 38
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 71 75 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Mmp13 mRNA levels determined by qPCR during normal development (*) and MMTV-PyMT induced tumor progression (black triangle) in the #4 mammary gland (n = 6+/-1 for each time point). Values represent mean+/-standard error of the mean (SEM).
###end p 38
###begin p 39
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 160 165 160 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 452 461 452 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g002">Fig. 2a&#8211;d</xref>
###xml 479 484 479 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 595 602 595 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g002">Fig. 2i</xref>
###xml 614 619 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 753 760 753 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g002">Fig. 2j</xref>
###xml 788 793 788 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 854 858 854 858 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 863 868 863 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp14</italic>
###xml 950 956 950 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g002">Fig. 2</xref>
###xml 102 106 <span type="species:ncbi:10090">mice</span>
To determine where Mmp13 was expressed, we performed in situ hybridization in tumors from 13-week-old mice, containing different stages of nuclear grading. The Mmp13 mRNA signal was seen in stromal fibroblast-like cells located in the tumor core in areas with invasive grade II and III carcinoma ("late carcinoma"), but was generally absent in the tumor periphery that was dominated by normal-looking mammary tissue, hyperplasia or MIN grade I and II (Fig. 2a-d). In particular, Mmp13 mRNA positive cells were often seen in stromal branches located close to the tumor cores with focal necrosis (Fig. 2i). Sporadic Mmp13 mRNA positive single cells and small cell clusters were also found in areas with strongly keratinized, squamous metaplastic changes (Fig. 2j). This focal expression of Mmp13 in the tumor core was very different from the expression of Mmp2 and Mmp14, which were found throughout the tumor stroma, including at the tumor periphery (Fig. 2 e-h), and in areas with hyperplasia, grade I and grade II MIN (not shown).
###end p 39
###begin title 40
Mmp13 mRNA is expressed by a subset of alpha-smooth muscle actin positive carcinoma-associated fibroblasts.
###end title 40
###begin p 41
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp14</italic>
###xml 348 353 348 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 833 838 833 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 953 958 953 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 0 4 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 34 38 <span type="species:ncbi:10090">mice</span>
MMTV-PyMT tumors from 13-week-old mice were processed for in situ hybridization for Mmp13 (a-e, i-l), Mmp2 (g), and Mmp14 (h). For clarity the hybridization signals (silver grains) are shown with dark-field illumination in b, d, f, g, and h. (c) and (d) are higher magnification of the area with grade III invasive carcinoma framed in (a) and (b). Mmp13 mRNA signal is seen in the areas with grade III invasive carcinoma (c-d, arrows), but not in the surrounding areas with grade I and II MIN (indicated by I and II in a and b). Mmp13 mRNA expression is restricted to the tumor core (f, white arrows), whereas Mmp2 (g) and Mmp14 (h) mRNAs are seen also in the tumor periphery (blue arrows, f, g, and h are adjacent sections). Stromal septae with Mmp13 mRNA positive signal (i, arrows) are seen in areas close to necrotic tissue (N). Mmp13 mRNA signal in tumor areas with squamous metaplasia showing keratinized (K) epithelium (j, arrows). Expression of Mmp13 mRNA is seen in alpha-smooth muscle-actin immunoreactive myofibroblasts (k and l, arrows), in some areas restricted to myofibroblasts in the delicate strands of stromal tissue within the cellular tumor (l, arrows). All sections were counter-stained with haematoxylin and eosin except (k and l) that were stained with haematoxylin only. Bars: a, b: 700 microm; c, d: 100 microm; e-i: 400 microm; j: 200 microm; k, l: 50 microm.
###end p 41
###begin p 42
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 107 114 107 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in situ</italic>
###xml 192 197 192 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 288 295 284 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g002">Fig. 2k</xref>
###xml 358 362 354 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen1">[12]</xref>
###xml 475 480 471 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 513 518 509 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 606 613 602 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g002">Fig. 2l</xref>
###xml 659 664 655 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 694 699 690 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 825 830 821 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 409 413 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
The localization of the cells that expressed Mmp13 suggested that they were myofibroblasts. Using combined in situ hybridization and immunohistochemical staining, we verified that most of the Mmp13 mRNA positive cells were positive for the myofibroblast marker alpha-smooth muscle-actin (Fig. 2k), paralleling the expression we found in human breast cancers [12]. Myofibroblasts are prevalent in the invasive MMTV-PyMT tumors, but only a small subpopulation was positive for Mmp13 mRNA. We noted that some of the Mmp13 mRNA positive myofibroblasts were located in narrow bands between tumor cell clusters (Fig. 2l). CD204 positive macrophages did not express Mmp13 mRNA and the location of the Mmp13 mRNA positive cells was not consistent with myoepithelial cells (data not shown), supporting our conclusion that the stromal Mmp13 mRNA expressing cells were myofibroblasts.
###end p 42
###begin title 43
###xml 48 52 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Early tumor formation does not require MMP13 in MMTV-PyMT
###end title 43
###begin p 44
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 239 247 239 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 350 357 350 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g003">Fig. 3A</xref>
###xml 519 522 519 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 514 522 514 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 726 729 726 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 711 729 711 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 749 752 749 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 734 752 734 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 759 766 759 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g003">Fig. 3B</xref>
###xml 797 802 797 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 173 178 <span type="species:ncbi:10090">mouse</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 504 508 <span type="species:ncbi:10090">mice</span>
###xml 523 527 <span type="species:ncbi:10090">mice</span>
###xml 608 612 <span type="species:ncbi:10090">mice</span>
###xml 711 715 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 734 738 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
The expression levels and patterns of Mmp13 mRNA suggested that the proteinase would play a role in the transition to the invasive stages. To determine the role of MMP13 in mouse mammary tumor progression, we took a genetic approach using Mmp13-/- mice. We verified that the absence of MMP13 did not affect the development of the mammary epithelium (Fig. 3A) and therefore would not affect tumor progression indirectly by influencing the number of mammary epithelial cells. We next crossed the MMTV-PyMT mice with Mmp13-/- mice and measured the total hyperplastic area on whole-mounts of mammary glands from mice at age 4 or 6 weeks, before the transition to invasive carcinoma. No difference was found between MMTV-PyMT;Mmp13+/+ and MMTV-PyMT;Mmp13-/- mice (Fig. 3B), consistent with the lack of Mmp13 mRNA expression at the early cancer stage.
###end p 44
###begin title 45
Mammary gland development and early tumor development is not influenced by MMP13.
###end title 45
###begin p 46
###xml 163 166 163 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 158 166 158 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13<sup>+/+</sup></italic>
###xml 233 236 233 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 228 236 228 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 638 641 638 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 623 641 623 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 661 664 661 664 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 646 664 646 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 753 756 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 738 756 738 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 808 811 808 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 793 811 793 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 543 547 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 623 627 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 646 650 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 665 669 <span type="species:ncbi:10090">mice</span>
###xml 738 742 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 793 797 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 812 816 <span type="species:ncbi:10090">mice</span>
(A) Morphometric analysis of ductal epithelial penetration during normal mammary gland development. Representative whole mount-stained #4 mammary glands from Mmp13+/+ (n = 4 and n = 4 at 4 and 6 weeks of age, respectively), and Mmp13-/- mice (n = 3 and n = 7 at 4 and 6 weeks of age, respectively. The distances from the nipple to the three most far-reaching ducts and to the edge of the fat pad were measured. The mean ductal epithelial penetration as percentage of the whole fat pad is shown with the SEM. (B) Morphometric analysis of early MMTV-PyMT tumor growth. Representative whole mount-stained #4 gland tumors from MMTV-PyMT;Mmp13+/+ and MMTV-PyMT;Mmp13-/- mice at 6-weeks-of-age. The tumor area was measured in 4- and 6-week-old MMTV-PyMT;Mmp13+/+ (n = 5 and n = 7, respectively) and MMTV-PyMT;Mmp13-/- mice (n = 3 and n = 10, respectively) and are presented as mean with the SEM.
###end p 46
###begin title 47
###xml 79 83 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
MMP13 is not required for tumor growth, tumor vascularization or metastasis in MMTV-PyMT mammary carcinomas
###end title 47
###begin p 48
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 271 274 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 261 274 261 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PyMT;Mmp13<sup>+/+</sup></italic>
###xml 303 306 303 306 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 288 306 288 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 567 570 567 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 552 570 552 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 609 616 609 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g004">Fig. 4A</xref>
###xml 670 677 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g004">Fig. 4B</xref>
###xml 783 786 783 786 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 768 786 768 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 806 809 806 809 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 791 809 791 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 871 878 871 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g005">Fig. 5C</xref>
###xml 1074 1081 1074 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g004">Fig. 4C</xref>
###xml 1108 1111 1108 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1093 1111 1093 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 1138 1141 1138 1141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1128 1141 1128 1141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PyMT;Mmp13<sup>+/+</sup></italic>
###xml 1294 1297 1294 1297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1279 1297 1279 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 1317 1320 1317 1320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1307 1320 1307 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PyMT;Mmp13<sup>+/+</sup></italic>
###xml 1513 1523 1513 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g005">Fig. 5A, B</xref>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 288 292 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 552 556 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 768 772 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 791 795 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 810 814 <span type="species:ncbi:10090">mice</span>
###xml 1093 1097 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1123 1127 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1279 1283 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1302 1306 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1321 1325 <span type="species:ncbi:10090">mice</span>
###xml 1507 1511 <span type="species:ncbi:10090">mice</span>
Mmp13 mRNA was induced in tumors from mice of 7-9 weeks-of-age, and we therefore expected that MMP13 would be required in the later stages of tumorigenesis, possibly affecting tumor growth and metastasis. We followed tumor growth in a cohort of littermate MMTV-PyMT;Mmp13+/+ (n = 38) and MMTV-PyMT;Mmp13-/- females (n = 25) by weekly palpations and caliper measurements until 13 weeks of age, when tumors were isolated for histological examination and the lungs isolated to determine metastasis burden. A minor reduction in the growth of the tumors in MMTV-PyMT;Mmp13-/- mice were seen at 8, 9, 11, 12 weeks (Fig. 4A), but this was not reproduced in a different cohort (Fig. 4B). Furthermore, there were no differences in cancer cell proliferation between tumors from MMTV-PyMT;Mmp13+/+ and MMTV-PyMT;Mmp13-/- mice at 8 or 11 weeks of age as determined by BrdU-labeling (Fig. 5C). In addition, histological examination and nuclear grading of the tumors revealed no significant differences in the percentages of tumors that had progressed to grade III, late-stage carcinoma (Fig. 4C, 8% of the MMTV-PyMT;Mmp13-/- vs. 18% of MMTV-PyMT;Mmp13+/+ tumors). Furthermore, analyses of H&E stained sections revealed no differences in the presence of necrosis or stroma between tumors from MMTV-PyMT;Mmp13-/- and MMTV-PyMT;Mmp13+/+ mice (not shown). Finally, no effects were seen on tumor vascularization, when analyzing vessel diameter, length, or volume in 3D reconstructions of vessels in tumors of lectin-perfused mice (Fig. 5A, B). Thus, the absence of MMP13 did not influence progression in the primary tumors.
###end p 48
###begin title 49
###xml 0 4 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
MMTV-PyMT primary tumor growth and metastasis is not influenced by MMP13.
###end title 49
###begin p 50
###xml 144 147 144 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 129 147 129 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 189 192 176 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 174 192 161 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 224 227 211 214 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 209 227 196 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 459 462 446 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 444 462 431 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 503 506 477 480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 488 506 462 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 602 605 574 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 587 605 559 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 655 658 625 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 640 658 610 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 843 846 813 816 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 828 846 798 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 875 878 845 848 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 860 878 830 848 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 1220 1221 1190 1191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1244 1247 1214 1217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1229 1247 1199 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 1267 1268 1237 1238 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 1296 1299 1266 1269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1281 1299 1251 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 4 8 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 129 133 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 174 178 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 209 213 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 444 448 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 488 492 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 587 591 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 606 610 <span type="species:ncbi:10090">mice</span>
###xml 640 644 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 659 663 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 828 832 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 860 864 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 888 892 <span type="species:ncbi:10090">mice</span>
###xml 1150 1154 <span type="species:ncbi:10090">mice</span>
###xml 1229 1233 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1281 1285 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1300 1304 <span type="species:ncbi:10090">mice</span>
(A) MMTV-PyMT tumor growth determined by weekly caliber measurements. Total tumor volumes are presented as mean +/- the SEM. (*) MMTV-PyMT;Mmp13+/+, n = 38, (black triangle) MMTV-PyMT;Mmp13-/-, n = 25 . Three MMTV-PyMT;Mmp13+/+ mice were terminated before the end of the experiment due to extensive tumor burden, one at 8 weeks and two after 12 weeks. (B) MMTV-PyMT tumor growth determined by weekly caliber measurements in another cohort. (*) MMTV-PyMT;Mmp13+/+, n = 6, (black triangle) MMTV-PyMT;Mmp13-/-, n = 7. The total weight of the tumors at 11 weeks was 1.42g+/-0.22 SEM for the MMTV-PyMT;Mmp13+/+ mice and 1.44g+/-0.16 SEM for the MMTV-PyMT;Mmp13-/- mice. (C) Nuclear grading of the MMTV-PyMT tumors. Nuclear grading was performed on representative H&E stained sections from mammary tumors glands #1-3 from 13-week-old MMTV-PyMT;Mmp13+/+ (n = 34) and MMTV-PyMT;Mmp13-/- (n = 24) mice by a pathologist (FR) unaware of the genotypes. Nuclear grading was independent of genotype. (D) Lung metastasis volumes determined by stereology using Cavalieri's principle. The total metastasis volume was determined in lungs obtained from the 13-week-old mice by an observer unaware of the genotypes. Median values are 1.2 mm3 in the MMTV-PyMT;Mmp13+/+ (n = 35) and 0.7 mm3 (n = 25) in MMTV-PyMT;Mmp13-/- mice, respectively.
###end p 50
###begin title 51
###xml 19 23 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Vascularization of MMTV-PyMT tumors is not affected by MMP13.
###end title 51
###begin p 52
###xml 375 378 375 378 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 360 378 360 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 406 409 406 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 391 409 391 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 830 833 830 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 815 833 815 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 900 903 900 903 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 885 903 885 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 176 199 <span type="species:ncbi:4081">lycopersicon esculentum</span>
###xml 360 364 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 391 395 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 410 414 <span type="species:ncbi:10090">mice</span>
###xml 524 528 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 601 605 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 808 813 <span type="species:ncbi:10090">mouse</span>
###xml 815 819 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 885 889 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
(A) Maximum intensity projections of confocal image stacks from tumor sections showing cell nuclei (red, propidium iodide stained) and vasculature (green, with FITC-conjugated lycopersicon esculentum lectin). (B) No significant differences were observed in vessel diameter (p = 0.95), length (p = 0.4) or volume (p = 0.4) when comparing vessels in tumors from MMTV-PyMT;Mmp13+/+ (n = 9) and MMTV-PyMT;Mmp13-/- mice (n = 9, t-tests). All analyses were done blindly. (C) Morphometric analysis of the proliferation rate in the MMTV-PyMT tumors. Representative immunohistochemical staining for BrdU in an MMTV-PyMT tumor with counting frames applied to the tissue sections (left). Tumor cell proliferation was determined by an observer unaware of the genotypes in one #1-3 gland and one #4 gland tumor from each mouse. MMTV-PyMT;Mmp13+/+, n = 8 and n = 11 at 8 and 11 weeks, respectively, MMTV-PyMT;Mmp13-/-, n = 7 and n = 12 at 8 and 11 weeks, respectively (three samples were excluded due to poor morphology). The proliferation rates are shown as the percentage of the total number of neoplastic cells with medians 50% (box) and 95% inclusion intervals (right).
###end p 52
###begin p 53
###xml 108 112 108 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-KourosMehr1">[16]</xref>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 216 219 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 178 219 178 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup> and MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen3">[29]</xref>
###xml 376 383 376 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g004">Fig. 4D</xref>
###xml 385 386 385 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g001">1</xref>
###xml 391 392 391 392 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 412 415 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 397 415 397 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 431 432 431 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 452 455 452 455 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 437 455 437 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 465 466 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 92 96 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 178 182 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 201 205 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 397 401 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 437 441 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 563 567 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Since MMP13 is upregulated concomitantly with the onset of cancer cell dissemination in the MMTV-PyMT model [16], we determined the metastatic burden in the lungs from end-stage MMTV-PyMT;Mmp13+/+ and MMTV-PyMT;Mmp13-/- mice using a morphometric approach [29]. Although there was a trend for a reduced lung metastatic volume in the absence of MMP13, this was not significant (Fig. 4D, 1.2 mm3 for MMTV-PyMT;Mmp13+/+, n = 35; 0.7 mm3 for MMTV-PyMT;Mmp13-/-, n = 25, p = 0.34). We therefore conclude that the absence of MMP13 does not affect lung metastasis in the MMTV-PyMT breast cancer model.
###end p 53
###begin title 54
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 68 72 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
There are no compensatory changes in expression of MMPs or TIMPs in MMTV-PyMT;Mmp13-/- tumors
###end title 54
###begin p 55
###xml 426 432 426 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g006">Fig. 6</xref>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
Since we found no changes in tumor progression in the absence of MMP13, we explored the possibility that the lack of MMP13 activity was compensated for by changes in expression of other MMPs or in their inhibitors, the TIMPs. However, there were no significant differences in the mRNA levels for MMP2, -3, -8, -9, -10, -11, -12, -13, -14 or TIMP1, -2, -3, or -4 in tumors with and without MMP13 from 11-week-old mice by qPCR (Fig. 6).
###end p 55
###begin title 56
Absence of MMP13 is not compensated for by changes in mRNA expression of other MMPs or TIMPs.
###end title 56
###begin p 57
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp</italic>
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Timp</italic>
###xml 83 86 83 86 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 68 86 68 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 101 102 101 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 127 130 127 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 112 130 112 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 144 145 144 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 257 260 257 260 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 242 260 242 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 333 335 333 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 342 344 342 344 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 68 72 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 112 116 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 242 246 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Expression of Mmp and Timp mRNAs, relative to 18S ribosomal RNA, in MMTV-PyMT;Mmp13+/+ (white boxes, n = 6) and MMTV-PyMT;Mmp13-/- (gray boxes, n = 6) tumors. In the box and whiskers plot, all values are normalized to the median value of the MMTV-PyMT;Mmp13+/+ group. Horizontal lines indicate the median and the boxes include the 25th and 75th percentiles. The lines outside the boxes correspond to highest or lowest values observed when these did not fall within the quartiles, and circles (white or gray) correspond to outlier values.
###end p 57
###begin title 58
###xml 96 100 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Increased amounts of thin collagen fibers is found in the absence of MMP13 in invasive areas of MMTV-PyMT tumors
###end title 58
###begin p 59
###xml 223 230 223 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g007">Fig. 7A</xref>
###xml 463 466 451 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 453 466 441 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 473 480 461 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002959-g007">Fig. 7B</xref>
###xml 448 452 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 467 471 <span type="species:ncbi:10090">mice</span>
###xml 572 576 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
To determine whether any effects of MMP13 could be seen on its major substrate, fibrillar collagen, we evaluated the fibrillar collagen content in invasive areas of the tumors by picrosirius red staining of tumor sections (Fig. 7A). Although total collagen was not affected by the absence of MMP13, the fraction of thin collagen fibers relative to total collagen was increased significantly by approximately30% in the invasive areas of tumors from MMTV-PyMT;Mmp13-/- mice (Fig. 7B, t-test, p = 0.007). Thus, MMP13 played a role in collagen metabolism in invasive areas of MMTV-PyMT tumors, but this did not affect tumor progression.
###end p 59
###begin title 60
###xml 54 58 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
Absence of MMP13 influences fibrillar collagen in the MMTV-PyMT tumor stroma.
###end title 60
###begin p 61
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 25 43 25 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 54 72 54 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 510 513 510 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 495 513 495 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 527 528 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 554 557 554 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 539 557 539 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 572 573 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 25 29 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 54 58 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 495 499 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 539 543 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
(A) Tissue sections from MMTV-PyMT;Mmp13+/+ (a-d) and MMTV-PyMT;Mmp13-/- (e-h) tumors stained with haematoxylin and eosin (a,e) or picrosirius red (b,f), the latter illuminated with linearly polarized light. Color threshold images of total collagen (c,g) and thin collagen fibers (d,h) of the images in b and f, respectively. (B) Box plots of total collagen (left), thin collagen fibers (middle) and the ratio between thin collagen fibers and total collagen (right, *p<0.01, t-test) measured in MMTV-PyMT;Mmp13+/+ (gray boxes, n = 26) and MMTV-PyMT;Mmp13-/- (white boxes, n = 21) tumors as shown in the A panel.
###end p 61
###begin title 62
Discussion
###end title 62
###begin p 63
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen1">[12]</xref>
###xml 504 512 504 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 519 523 519 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Rizki1">[33]</xref>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 90 94 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
###xml 620 624 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1006 1010 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
In this study, we analyzed the effects of absence of MMP13 activity on the progression of MMTV-PyMT mammary carcinoma. Our previous studies of human DCIS with early invasion led us to hypothesize that MMP13 would be a fibroblast-derived, potential rate-limiting proteinase in the transition from non-invasive to invasive breast carcinoma [12]. Interestingly, a recent study reported upregulation of several MMPs, including MMP13, at the transition from non-invasive to invasive breast cancer cells in an in vitro model [33]. However, although Mmp13 mRNA also was strongly induced in a subpopulation of myofibroblasts in MMTV-PyMT mammary carcinomas, concurrent with early transition to invasive carcinoma, there were no effects on tumor cell proliferation, tumor growth, lung metastasis, vascularization or differentiation of the primary tumors by the absence of MMP13. We excluded that the lack of effects was due to compensatory transcriptional changes of other MMPs or their inhibitors expressed in the MMTV-PyMT tumors.
###end p 63
###begin p 64
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Knauper2">[11]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Fosang1">[34]</xref>
###xml 131 135 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Knuper1">[35]</xref>
###xml 137 142 137 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 406 409 406 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 391 409 391 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 437 440 437 440 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 422 440 422 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>+/+</sup></italic>
###xml 585 590 585 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 633 637 633 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Stickens1">[21]</xref>
###xml 639 643 639 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Inada1">[36]</xref>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Stickens1">[21]</xref>
###xml 756 760 756 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Inada1">[36]</xref>
###xml 784 788 784 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Behonick1">[37]</xref>
###xml 820 824 820 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Deguchi1">[38]</xref>
###xml 230 234 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 391 395 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 422 426 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 554 558 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 572 576 <span type="species:ncbi:10090">Mice</span>
MMP13 has a broad substrate profile that includes several fibrillar collagens, tenascin, fibronectin and proteoglycans [11], [34], [35]. Mmp13 mRNA was found in carcinoma-associated fibroblasts located in the central areas of the MMTV-PyMT tumors, where tumor dedifferentiation and invasion is prominent. In these areas, we found increased thin collagen fibers relative to total collagen in MMTV-PyMT;Mmp13-/- compared to MMTV-PyMT;Mmp13+/+ tumors, indicating that MMP13 influences collagen fiber formation and/or metabolism of fibrillar collagen in the MMTV-PyMT stroma. Mice lacking Mmp13 display no major phenotypic abnormalities [21], [36], but a significant contribution of MMP13 in collagen metabolism has been reported during bone development [21], [36], skeletal regeneration [37] and in atherosclerotic plaques [38].
###end p 64
###begin p 65
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Sappino1">[39]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Cunha1">[40]</xref>
###xml 357 361 357 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Omary1">[42]</xref>
###xml 499 503 499 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Nielsen4">[43]</xref>
###xml 505 509 505 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Offersen1">[44]</xref>
###xml 538 543 538 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 628 633 628 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 780 788 780 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 898 903 888 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 935 939 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Uria1">[45]</xref>
###xml 1070 1074 1054 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Cheng1">[46]</xref>
###xml 1076 1081 1060 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 1281 1286 1265 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 1336 1340 1320 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Koong1">[47]</xref>
###xml 1341 1345 1325 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Vajner1">[49]</xref>
###xml 1368 1372 1352 1356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Vajner1">[49]</xref>
###xml 1482 1485 1466 1469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1477 1485 1461 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 1491 1495 1475 1479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Kosaki1">[50]</xref>
###xml 61 65 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 169 173 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 220 225 <span type="species:ncbi:9606">human</span>
###xml 490 498 <span type="species:ncbi:9606">patients</span>
###xml 707 711 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1486 1490 <span type="species:ncbi:10090">mice</span>
###xml 1567 1571 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
We found that most of the Mmp13 mRNA expressing cells in the MMTV-PyMT tumors are carcinoma-associated myofibroblasts. The myofibroblast is an abundant cell type in the MMTV-PyMT tumors (this study) as it is in invasive human breast cancers [39]. There are several reports suggesting that carcinoma-associated myofibroblasts promote cancer progression [40]-[42]. In addition, proteins expressed by myofibroblasts, such as PAI-1 and uPA, are associated with poor prognosis for breast cancer patients [43], [44]. It is unknown what induces Mmp13 in the breast carcinoma-associated myofibroblasts, but the restricted expression of Mmp13 in dense fibrous stromal septae within the central parts of the invasive MMTV-PyMT tumors suggests a locally expressed tumor-cell derived factor. In vitro studies have shown that IL-1alpha, IL-1beta, and transforming growth factor-beta1, in particular, can induce Mmp13 mRNA expression in fibroblasts [45]. Interestingly, TGFbeta signaling through fibroblast-expressed TGFbeta receptor type II has a considerable impact on tumor growth [46]. Mmp13 mRNA expressing myofibroblasts are often found in the tumor core close to areas with necrosis suggesting that MMP13 may be upregulated in response to hypoxia for stimulation of angiogenesis. Indeed, Mmp13 mRNA is induced by hypoxia in various cell lines [47]-[49] including fibroblasts [49], and vasculature of ossification sites and migration of endothelial cells into cartilage is impaired in Mmp13-/- mice [50]. However, our measurements of vascular diameter, length and volumes in MMTV-PyMT tumors did not reveal any effect of MMP13 on tumor vascularization.
###end p 65
###begin p 66
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp9</italic>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 115 123 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 129 133 129 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Inada1">[36]</xref>
###xml 143 147 143 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp8</italic>
###xml 202 205 202 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 197 205 197 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Hartenstein1">[51]</xref>
###xml 309 312 309 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 294 312 294 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 548 553 548 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp10</italic>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp12</italic>
###xml 597 601 597 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 836 841 836 841 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP10</italic>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMP12</italic>
###xml 915 918 915 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 900 918 900 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 1148 1153 1148 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp13</italic>
###xml 1212 1216 1212 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 1221 1226 1221 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp14</italic>
###xml 1359 1363 1359 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp2</italic>
###xml 1365 1369 1365 1369 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp3</italic>
###xml 1371 1376 1371 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp11</italic>
###xml 1381 1386 1381 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp14</italic>
###xml 1431 1435 1431 1435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Pedersen1">[18]</xref>
###xml 1549 1556 1549 1556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1556 1559 1556 1559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Egeblad1">[3]</xref>
###xml 1672 1675 1672 1675 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1657 1675 1657 1675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT;Mmp13<sup>&#8722;/&#8722;</sup></italic>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 294 298 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 394 398 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 808 812 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 900 904 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 938 942 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1408 1412 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1657 1661 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
It has been reported that Mmp8 and Mmp9 mRNAs are upregulated during bone development in the ossification sites in Mmp13-/- mice [36] and that Mmp8 mRNA is upregulated during skin wound healing in Mmp13-/- mice [51]. We tested whether the mRNA expression levels of several MMPs were changed in MMTV-PyMT;Mmp13-/- tumors, but found no significant changes. We found that tumor progression in the MMTV-PyMT model was associated with strong upregulation of the Mmp13 mRNA level as compared to the normal mammary gland. Preliminary results suggest that Mmp10 and Mmp12 mRNA also are upregulated, while Mmp2, -3, -8, -9, -11, and -14 are not (TXP, CP, DE, unpublished data). This suggests that the three MMPs are upregulated by a common mechanism and potentially implicates MMP10 and MMP12 in tumorigenesis in the MMTV-PyMT model even though MMP10 and MMP12 mRNAs were not significantly upregulated in the MMTV-PyMT;Mmp13-/- tumors compared to MMTV-PyMT wild type tumors. However, we cannot exclude that differences exist at the level of enzyme activity or that other classes of proteolytic enzymes compensate for the absence of MMP13. The expression of Mmp13 mRNA is strongly restricted compared to the expression of Mmp2 and Mmp14 mRNAs that are expressed in a broader group of (myo)fibroblasts. We have previously reported that mRNAs for several MMPs, including Mmp2, Mmp3, Mmp11 and Mmp14 are expressed in the MMTV-PyMT tumor stroma [18]. Of these MMPs, MMP2 and MMP14 may have substrates in common with MMP13, for example, both are also collagenases in vivo[3]. Therefore MMP2, MMP14 or the activity of other MMPs may compensate for the lack of MMP13 in the MMTV-PyMT;Mmp13-/- tumors.
###end p 66
###begin p 67
###xml 311 315 311 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mmp9</italic>
###xml 394 397 394 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Coussens1">[4]</xref>
###xml 511 515 511 515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-LopezOtin1">[52]</xref>
###xml 151 155 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 241 246 <span type="species:ncbi:9606">human</span>
It is possible that MMP13 plays both promoting and inhibiting roles during cancer progression, resulting in a neutral net effect in its absence in the MMTV-PyMT model. Tumor promoting and inhibiting functions have been found for MMP9 in the human papilloma virus (HPV) 16 skin cancer model where the absence of Mmp9 reduced the number of tumors, but the tumors that formed were more aggressive [4]. A tumor protective role of a number of matrix degrading proteases, including MMP8 and MMP12, has been described [52]. These studies emphasize the need for better understanding the role not only of the individual proteases but also of their separate activities in cancer progression.
###end p 67
###begin p 68
###xml 182 185 182 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Almholt1">[6]</xref>
###xml 323 327 323 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Guy1">[14]</xref>
###xml 329 333 329 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lin1">[15]</xref>
###xml 335 339 335 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Maglione1">[17]</xref>
###xml 567 576 567 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MMTV-PyMT</italic>
###xml 612 616 612 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Lin1">[15]</xref>
###xml 29 35 <span type="species:ncbi:9606">humans</span>
###xml 101 107 <span type="species:ncbi:10090">murine</span>
###xml 122 127 <span type="species:ncbi:9606">human</span>
###xml 175 181 <span type="species:ncbi:10090">murine</span>
###xml 205 209 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 295 300 <span type="species:ncbi:9606">human</span>
###xml 361 366 <span type="species:ncbi:9606">human</span>
###xml 567 571 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 723 728 <span type="species:ncbi:9606">human</span>
###xml 985 989 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1075 1079 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 1103 1108 <span type="species:ncbi:9606">human</span>
###xml 1215 1220 <span type="species:ncbi:9606">human</span>
Breast cancer progression in humans may have a larger contribution from the stromal environment than murine tumors, since human tissue have a more fibroblast-rich stroma than murine [6]. Nevertheless, the MMTV-PyMT breast cancer model shares many histological and molecular characteristics with human luminal breast cancer [14], [15], [17], but it differs from human ductal carcinoma in one interesting aspect: the myoepithelial cells, which represent a cellular barrier for tumor cells and are an important source for basement membrane, are partly lost early during MMTV-PyMT oncogene-induced tumor progression [15]. The absence of an intact myoepithelial barrier may lead to pre-invasive precursor lesions different from human DCIS and render MMP13 a dispensable proteinase in the critical transition phase from non-invasive to invasive carcinoma. Thus, despite the presence of a heterogeneous stromal environment and the appearance of a considerable myofibroblast population in the MMTV-PyMT tumors, myofibroblasts may play a minor role for the overall progression of the MMTV-PyMT tumor compared to human breast cancer. Therefore, models in which transition from DCIS to invasive carcinoma occurs similar to in human tumors are needed to definitely rule out a role of MMP13 in breast cancer.
###end p 68
###begin p 69
###xml 327 331 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Olumi1">[53]</xref>
###xml 332 336 332 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002959-Gaggioli1">[55]</xref>
###xml 57 61 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 514 518 <span type="species:ncbi:11757?0.9246724890829694">MMTV</span>
In conclusion, we found that the absence of MMP13 in the MMTV-PyMT mice did not result in any differences in tumor progression to invasive and metastatic breast carcinoma. Carcinoma-associated fibroblasts have been shown to facilitate tumor progression through stimulation of angiogenesis, growth factor secretion and invasion [53]-[55]. However, there are no good markers allowing systematic sub-classification of these cells. Thus, even though MMP13 itself apparently is dispensable for tumor progression in the MMTV-PyMT model, its restricted expression in myofibroblasts in invasive regions suggests that it marks a subpopulation of carcinoma-associated fibroblasts that are involved in the transition to invasive carcinoma.
###end p 69
###begin p 70
Charlotte Lonborg, Lotte Frederiksen, Oznur Turan and Birthe Larsen for excellent technical assistance and John Post for photographic assistance.
###end p 70
###begin title 71
References
###end title 71
###begin article-title 72
###xml 50 55 <span type="species:ncbi:9606">human</span>
Changes in the extracellular matrix of the normal human breast during the menstrual cycle.
###end article-title 72
###begin article-title 73
Involvement of extracellular matrix constituents in breast cancer.
###end article-title 73
###begin article-title 74
New functions for the matrix metalloproteinases in cancer progression.
###end article-title 74
###begin article-title 75
MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis.
###end article-title 75
###begin article-title 76
Matrix metalloproteinases and tumor metastasis.
###end article-title 76
###begin article-title 77
###xml 40 45 <span type="species:ncbi:10090">Mouse</span>
Extracellular Proteolysis in Transgenic Mouse Models of Breast Cancer.
###end article-title 77
###begin article-title 78
MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease.
###end article-title 78
###begin article-title 79
###xml 59 64 <span type="species:ncbi:9606">human</span>
Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas.
###end article-title 79
###begin article-title 80
###xml 24 29 <span type="species:ncbi:9606">human</span>
Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme.
###end article-title 80
###begin article-title 81
Induction of matrix metalloproteinase activation cascades based on membrane-type 1 matrix metalloproteinase.
###end article-title 81
###begin article-title 82
###xml 32 37 <span type="species:ncbi:9606">human</span>
Biochemical characterization of human collagenase-3.
###end article-title 82
###begin article-title 83
Collagenase-3 (MMP-13) expression in breast myofibroblasts as a molecular marker of transition of ductal caricnoma in situ lesions to invasive ductal carcinomas.
###end article-title 83
###begin article-title 84
###xml 53 58 <span type="species:ncbi:9606">human</span>
Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ co-express urokinase and urokinase receptor.
###end article-title 84
###begin article-title 85
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
###end article-title 85
###begin article-title 86
###xml 62 67 <span type="species:ncbi:10090">mouse</span>
###xml 118 123 <span type="species:ncbi:9606">human</span>
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases.
###end article-title 86
###begin article-title 87
GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model.
###end article-title 87
###begin article-title 88
###xml 28 32 <span type="species:ncbi:10090">mice</span>
Transgenic Polyoma middle-T mice model premalignant mammary disease.
###end article-title 88
###begin article-title 89
###xml 96 101 <span type="species:ncbi:10090">mouse</span>
Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas.
###end article-title 89
###begin article-title 90
###xml 61 67 <span type="species:ncbi:10090">murine</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors.
###end article-title 90
###begin article-title 91
Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinoma.
###end article-title 91
###begin article-title 92
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Altered endochondral bone development in matrix metalloproteinase 13-deficient mice.
###end article-title 92
###begin article-title 93
Simplified mammalian DNA isolation procedure.
###end article-title 93
###begin article-title 94
###xml 101 105 <span type="species:ncbi:10090">mice</span>
Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice.
###end article-title 94
###begin article-title 95
###xml 110 115 <span type="species:ncbi:9606">human</span>
Elevated membrane-type matrix metalloproteinases in gliomas revealed by profiling proteases and inhibitors in human cancer cells.
###end article-title 95
###begin article-title 96
The role of chondrocyte senescence in osteoarthritis.
###end article-title 96
###begin article-title 97
###xml 76 80 <span type="species:ncbi:10090">mice</span>
An adverse role for matrix metalloproteinase 12 after spinal cord injury in mice.
###end article-title 97
###begin article-title 98
Functional overlap between two classes of matrix-degrading proteases in wound healing.
###end article-title 98
###begin article-title 99
Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis.
###end article-title 99
###begin article-title 100
###xml 61 67 <span type="species:ncbi:10090">murine</span>
A precise and efficient stereological method for determining murine lung metastasis volumes.
###end article-title 100
###begin article-title 101
Lack of plasminogen leads to milk stasis and premature mammary gland involution during lactation.
###end article-title 101
###begin article-title 102
Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections.
###end article-title 102
###begin article-title 103
Are the polarization colors of picrosirius red-stained collagen determined only by the diameter of the fibers?
###end article-title 103
###begin article-title 104
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human breast cell model of preinvasive to invasive transition.
###end article-title 104
###begin article-title 105
Degradation of cartilage aggrecan by collagenase-3 (MMP-13).
###end article-title 105
###begin article-title 106
###xml 37 42 <span type="species:ncbi:9606">human</span>
The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3.
###end article-title 106
###begin article-title 107
Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification.
###end article-title 107
###begin article-title 108
Role of Matrix Metalloproteinase 13 in Both Endochondral and Intramembranous Ossification during Skeletal Regeneration.
###end article-title 108
###begin article-title 109
###xml 102 107 <span type="species:ncbi:10090">mouse</span>
Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques.
###end article-title 109
###begin article-title 110
Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues.
###end article-title 110
###begin article-title 111
Role of the stromal microenvironment in carcinogenesis of the prostate.
###end article-title 111
###begin article-title 112
Heterogeneity of stromal fibroblasts in tumors.
###end article-title 112
###begin article-title 113
The pancreatic stellate cell: a star on the rise in pancreatic diseases.
###end article-title 113
###begin article-title 114
Urokinase plasminogen activator is localized in stromal cells in ductal breast cancer.
###end article-title 114
###begin article-title 115
###xml 95 100 <span type="species:ncbi:9606">human</span>
The myofibroblast is the predominant plasminogen activator inhibitor-1 expressing cell type in human breast cancer.
###end article-title 115
###begin article-title 116
###xml 42 47 <span type="species:ncbi:9606">human</span>
Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions.
###end article-title 116
###begin article-title 117
Loss of TGF-beta type II receptor in fibroblasts promotes mammary carcinoma growth and invasion through upregulation of TGF-alpha-, MSP- and HGF-mediated signaling networks.
###end article-title 117
###begin article-title 118
Candidate genes for the hypoxic tumor phenotype.
###end article-title 118
###begin article-title 119
###xml 105 110 <span type="species:ncbi:9606">human</span>
Hypoxia modulates the effects of transforming growth factor-beta isoforms on matrix-formation by primary human lung fibroblasts.
###end article-title 119
###begin article-title 120
###xml 153 157 <span type="species:ncbi:10116">rats</span>
Acute and chronic hypoxia as well as 7-day recovery from chronic hypoxia affects the distribution of pulmonary mast cells and their MMP-13 expression in rats.
###end article-title 120
###begin article-title 121
###xml 72 76 <span type="species:ncbi:10090">mice</span>
Impaired bone fracture healing in matrix metalloproteinase-13 deficient mice.
###end article-title 121
###begin article-title 122
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice.
###end article-title 122
###begin article-title 123
Emerging roles of proteases in tumour suppression.
###end article-title 123
###begin article-title 124
###xml 71 76 <span type="species:ncbi:9606">human</span>
Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium.
###end article-title 124
###begin article-title 125
###xml 40 45 <span type="species:ncbi:9606">human</span>
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.
###end article-title 125
###begin article-title 126
Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells.
###end article-title 126
###begin p 127
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 127
###begin p 128
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: The study was financially supported by the Danish Cancer Society, the Meyer Foundation, the Danish Medical Research Council (ME), the European Commission: grant number LSHC-CT-2003-503297 (Cancerdegradome) and FP7 grant (Microenvimet), and by the National Cancer Institute (USA) grants CA057621 and CA072006 (ZW). None of these supporting institutions played any role during the study and manuscript preparation.
###end p 128

